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Abstract  
            Transvenous pacemaker lead implantation is the preferred method of pacing in adult 
patients. Lead performance and longevity are superior and the implantation approach can be 
performed under local anaesthetic with a very low morbidity. In children, and especially in 
neonates and infants, the epicardial route was traditionally chosen until the advent of smaller 
generators and lead implantation techniques that allowed growth of the child without lead 
displacement. Endocardial implantation is not universally accepted, however, as there is an 
incidence of venous occlusion of the smaller veins of neonates and infants with concerns for loss 
of venous access in the future. Growing experience with lower profile leads, however, reveals 
that endocardial pacing too can be performed with low morbidity and good long-term results in 
neonates and infants.
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            Cardiac pacing in infants and children has evolved considerably since the initial implants 
over half a century ago. Pacemaker generators have become smaller and are now easily 
accommodated subcutaneously or submuscularly either in the chest or the abdominal wall in the 
smallest of infants. Improvements in lead technology have enabled lower chronic thresholds with 
greater mechanical and electrical integrity and longevity of the leads and the pacemaker system. 
While endocardial leads have consistently proven to be superior to epicardial leads both 
mechanically and electrically, the development of steroid eluting epicardial leads has improved 
the effectiveness of epicardial systems1. The child who receives a pacemaker will undergo 
several additional interventions to replace the generator with or without the lead itself during 
his/her lifetime. Special consideration should therefore be given when selecting the most 
appropriate pacing system in the very small.
            The choice of the method of permanent pacing is determined by the patient’s size, and 
presence of structural heart disease. While a large body of opinion holds that neonates and 
infants should receive epicardial pacing systems2-4, experience with endocardial leads in the 
smallest of infants is building up (Figure 1). The favourable outcome of endocardial leads in 
small infants is not limited to anecdotal case reports5-10. The largest experience to date from two 
centres (Guy’s Hospital and Wilhelmina Children’s Hospital) in 39 infants ≤ 10kg was published 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 6(2): 57-62 (2006)Canan Ayabakan, Eric Rosenthal,                                                                                             58 
“Endocardial Pacemaker Implantation in Neonates and Infants” 
recently by Kammeraad et al11. After a relatively long follow-up period of a median 4.3 years 
(up to 15.3 years), 31 of 36 patients (86%) continued with an endocardial system and 27 of them 
had the original endocardial lead. Two endocardial systems had to be replaced with epicardial 
systems and pacing therapy was stopped in three patients because it was no longer indicated. 
Lead survival was excellent with 87% of those with their first or second generator continuing 
with the original lead - comparable to the results of epicardial leads in older children12. Indeed in 
a similarly aged cohort, a significant number of epicardial lead failures were reported in neonates 
within the first year of implantation due to acute exit block and lead fractures13.
Figure 1. Left panel shows lead position in a baby with congenital complete heart 
block who was born prematurely with hydrops. A transvenous endocardial 
pacemaker was implanted at the age of 8 weeks when she weighed 2.95 kg. At 5 
years of age (weight 17.2 kg), she still has the initial lead and generator (right 
panel). The redundant loop of lead formed in the right atrium has not yet been 
taken up and will allow generator replacement without the need for lead 
advancemenrt.
Venous obstruction
            Endocardial leads are increasingly preferred for small infants in other centres as well14-16. 
The reasons for this preference are lower acute and chronic threshold values and decreased 
surgical morbidity from the procedure. The risk of venous occlusion, however, is the major 
drawback of endocardial lead placement in neonates and infants. If an adequate amount of slack 
is not left in the heart to cater for growth and the lead cannot be advanced, then replacement will 
be needed. If the lead cannot be replaced due to venous occlusion then the contralateral 
subclavian vein will need to be used and this may reduce the options for venous access in the 
future. Although transfemoral and transhepatic pacing can be performed with good results, few 
centres advocate these routinely17-18. Accordingly some centres still prefer to implant epicardial 
leads in children less than 10 kg2-4,13. In some centres the policy is one of replacing epicardial 
systems electively with an endocardial system at the end of life of the first generator due to an 
increase in lead fractures with time13. 
            Studies specifically comparing pacing via the endocardial route versus the epicardial 
route in small infants are lacking. The incidence of venous obstruction and occlusion has rarely 
been addressed. Venous obstruction due to endocardial leads in a small group of newborns and 
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infants was assessed by Stojanov et al16. In 12 children younger than 12 months, who had 
endocardial leads implanted via the cephalic vein, only two had ultrasonographic evidence of 
partial (up to 20%) venous occlusion at the end of a mean follow-up of 85.2 pacing months. 
Only four patients were reported to have asymptomatic venous occlusion during lead extraction 
among the 36 neonates and infants reported by Kammeraad et al11. Asymptomatic venous 
occlusion was not systematically looked for however, and the incidence may therefore be higher 
in this cohort who had their leads implanted via a subclavian puncture. Even in older children, 
the incidence of venous occlusion may be as high as 21% in endocardial leads depending on the 
lead diameter, body surface area and the introduction site (subclavian vein versus cephalic vein) 
of the lead19.
             Stojanov et al promote a cephalic vein cut down rather than a subclavian puncture 
approach in the very small15. It may be that avoidance of the relatively large sheath needed for a 
subclavian puncture to introduce the lead tip, which is larger than the lead body, has an 
advantage. Whether late venous obstruction depends more on the size of the subclavian 
introducer and acute trauma produced at the time of vein puncture or the diameter of the lead left 
in the vein has not been systematically investigated.
Lead Extraction
            Endocardial pacing in neonates is not for the faint-hearted as lead replacement is likely to 
be needed in at least some of the patients. While extracting 11 leads uneventfully in nine patients 
(including atrial leads placed at the second or third system), Kammeraad et al11 had to abandon a 
ventricular lead, which was adherent to the atrial myocardium. Extraction techniques are 
continuing to improve and lead replacement through an occluded subclavian vein is now 
possible   using   countertraction   sheaths.   A   technique   for   femoral   extraction   that   allows 
preservation of guidewire access across an occluded subclavian vein (Figure 2) is described by 
Kammeraad et al11. Downsizing extraction countertraction sheaths for smaller leads may allow 
their safe use even in small children. In older children, standard diathermy and laser extraction 
sheaths can be used safely.
Concomittant Cardiac Surgery
            Although epicardial leads do not carry a risk of venous thrombosis, there is an increased 
perioperative morbidity13. Patients who are already a candidate for a sternotomy or thoracotomy 
for the correction of heart defects may benefit from epicardial leads especially when dual 
chamber   pacing  is   required  for   atrioventricular   synchrony   to   improve  the  postoperative 
hemodynamics. However postoperative infections and pericarditis may preclude epicardial lead 
placement, in which case an endocardial pacing system is the best choice11,13. While some 
surgical heart block patients require dual chamber pacing, the majority of infants and neonates 
who require pacing, are well served by a single chamber system that can be implanted 
endocardially. Transvenous dual chamber pacing is possible but generally avoided due to the 
increased risks of venous occlusion11,14. Early pacing with a dual chamber system may lead to a 
cardiomyopathy due to pacing induced ventricular dysynchrony which is aggravated by the 
higher rates found with atrial tracking in the very young20,21
Conclusions
            Neither the epicardial nor the endocardial approach in permanent pacing is free from 
complications. The experience reported with endocardial pacing in neonates and infants while 
encouraging is limited and no directly comparative data with epicardial pacing are available. 
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Although the clear advantage of endocardial pacemaker implantation over the epicardial 
approach has yet to be demonstrated, the growing experience indicates that endocardial pacing is 
feasible and effective even in neonates and small infants - and it is an acceptable alternative to 
epicardial systems. The current disadvantages of endocardial leads may be overcome in the 
future by downsizing of the leads and extraction systems. The ultimate approach in very small 
children currently will depend on the facilities and experience of the surgeons and cardiologists 
in each centre.
Figure 2. An infant with congenitally corrected transposition (cTGA) developed 
heart failure with the onset of complete heart block and was paced at 6 weeks of 
age (a). At 4 years the generator reached its end of life with some remaining lead 
slack (b). During the generator change, the lead was inadvertently damaged and 
had to be replaced. Angiography revealed an occluded subclavian vein (c). To 
avoid the use of large countertraction sheaths from the subclavian approach, a 
coronary guidewire was passed into the lead stylet channel and was drawn out the 
femoral sheath with the lead after snaring the lead with the help of a tip deflector 
wire (d). Over the subclavian-femoral guidewire circuit, a new sheath was placed 
to implant a new ventricular lead (e).
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